表：用于阿尔茨海默病的淀粉样蛋白定向抗体。 - Suppr | 超能文献

Table: Amyloid-directed antibodies for Alzheimer's disease.

出版信息

Med Lett Drugs Ther. 2024 Aug 5;66(1708):e1-e2. doi: 10.58347/tml.2024.1708e.

DOI:10.58347/tml.2024.1708e

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Table: Amyloid-directed antibodies for Alzheimer's disease.表：用于阿尔茨海默病的淀粉样蛋白定向抗体。

Med Lett Drugs Ther. 2024 Aug 5;66(1708):e1-e2. doi: 10.58347/tml.2024.1708e.

2

Donanemab (Kisunla) for Alzheimer's disease.多奈单抗（Kisunla）用于治疗阿尔茨海默病。

Med Lett Drugs Ther. 2024 Aug 19;66(1709):129-131. doi: 10.58347/tml.2024.1709a.

3

What's in It for Me? Contextualizing the Potential Clinical Impacts of Lecanemab, Donanemab, and Other Anti-β-amyloid Monoclonal Antibodies in Early Alzheimer's Disease.对我有什么好处？在早期阿尔茨海默病中，情境化评估 LeCanemab、Donanemab 和其他抗β-淀粉样蛋白单克隆抗体的潜在临床影响。

eNeuro. 2024 Sep 27;11(9). doi: 10.1523/ENEURO.0088-24.2024. Print 2024 Sep.

4

[Mechanism of action and clinical trial results of Lecanemab (Leqembi 200 ‍mg, 500 ‍mg for Intravenous Infusion), a novel treatment for Alzheimer's disease].[抗阿尔茨海默病新药Lecanemab（静脉输注用Leqembi，规格200mg、500mg）的作用机制及临床试验结果]

Nihon Yakurigaku Zasshi. 2024;159(3):173-181. doi: 10.1254/fpj.24005.

5

[Immunotherapy for Alzheimer's disease].[阿尔茨海默病的免疫疗法]

Ugeskr Laeger. 2016 Jan 18;178(3):V07150588.

6

Structural aspects of Alzheimer's disease immunotherapy targeted against amyloid-beta peptide.针对淀粉样β肽的阿尔茨海默病免疫疗法的结构方面

Bratisl Lek Listy. 2018;119(4):201-204. doi: 10.4149/BLL_2018_037.

7

Are antibodies directed against amyloid-β (Aβ) oligomers the last call for the Aβ hypothesis of Alzheimer's disease?针对淀粉样β（Aβ）寡聚体的抗体是阿尔茨海默病Aβ假说的最后希望吗？

Immunotherapy. 2019 Jan;11(1):3-6. doi: 10.2217/imt-2018-0119.

8

Lecanemab and Donanemab as Therapies for Alzheimer's Disease: An Illustrated Perspective on the Data.莱卡奈单抗和多奈单抗治疗阿尔茨海默病：数据的图解视角

eNeuro. 2024 Jul 1;11(7). doi: 10.1523/ENEURO.0319-23.2024. Print 2024 Jul.

9

How promising are the latest monoclonal antibodies targeting amyloid-β for the treatment of early Alzheimer's disease?针对淀粉样蛋白-β的最新单克隆抗体治疗早期阿尔茨海默病的前景如何？

Expert Opin Emerg Drugs. 2024 Mar;29(1):35-43. doi: 10.1080/14728214.2024.2304059. Epub 2024 Jan 12.

10

Novel strategies for Alzheimer's disease treatment: An overview of anti-amyloid beta monoclonal antibodies.阿尔茨海默病治疗的新策略：抗淀粉样β单克隆抗体概述

Indian J Pharmacol. 2016 Nov-Dec;48(6):629-636. doi: 10.4103/0253-7613.194867.